Free Trial

16,874 Shares in ZimVie Inc. (NASDAQ:ZIMV) Acquired by Wealthquest Corp

ZimVie logo with Medical background

Key Points

  • Wealthquest Corp has acquired 16,874 shares of ZimVie Inc., valued at approximately $182,000, during the first quarter, holding about 0.06% of the company's stock.
  • Analysts have mixed ratings on ZimVie, with B. Riley downgrading the stock from "buy" to "neutral" and setting a price target of $19.00, while Barclays upgraded it to "equal weight" with a revised price objective of $19.00 as well.
  • ZimVie shares are currently trading at $18.79, showing a 12-month low of $8.15 and a high of $21.53, amidst a market capitalization of $523.30 million.
  • Want stock alerts on ZimVie? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Wealthquest Corp bought a new position in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 16,874 shares of the company's stock, valued at approximately $182,000. Wealthquest Corp owned approximately 0.06% of ZimVie as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. J. Goldman & Co LP boosted its holdings in shares of ZimVie by 167.5% during the 4th quarter. J. Goldman & Co LP now owns 1,425,810 shares of the company's stock valued at $19,890,000 after acquiring an additional 892,785 shares in the last quarter. American Century Companies Inc. raised its position in shares of ZimVie by 23.9% in the 4th quarter. American Century Companies Inc. now owns 628,050 shares of the company's stock worth $8,761,000 after acquiring an additional 121,053 shares in the last quarter. Dimensional Fund Advisors LP increased its position in ZimVie by 9.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,244,938 shares of the company's stock valued at $17,367,000 after buying an additional 107,461 shares in the last quarter. Mill Road Capital Management LLC acquired a new position in ZimVie during the 4th quarter valued at about $1,401,000. Finally, Ancora Advisors LLC boosted its stake in shares of ZimVie by 460.8% in the 4th quarter. Ancora Advisors LLC now owns 112,160 shares of the company's stock worth $1,565,000 after buying an additional 92,160 shares during the last quarter. Institutional investors own 95.63% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ZIMV shares. Wall Street Zen cut shares of ZimVie from a "strong-buy" rating to a "buy" rating in a report on Friday, July 18th. Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. UBS Group reduced their target price on ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a research note on Thursday, May 15th. B. Riley cut ZimVie from a "buy" rating to a "neutral" rating and set a $19.00 target price on the stock. in a research note on Thursday, July 31st. Finally, Barclays raised ZimVie from an "underweight" rating to an "equal weight" rating and increased their target price for the company from $9.00 to $19.00 in a research note on Tuesday, July 22nd. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $17.75.

Read Our Latest Stock Report on ZimVie

ZimVie Stock Up 0.2%

ZIMV traded up $0.04 during trading on Tuesday, hitting $18.81. 226,085 shares of the company's stock traded hands, compared to its average volume of 282,872. ZimVie Inc. has a 12-month low of $8.15 and a 12-month high of $18.98. The company has a current ratio of 2.37, a quick ratio of 1.60 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $530.30 million, a price-to-earnings ratio of -26.88 and a beta of 2.20. The company's 50 day simple moving average is $11.28 and its two-hundred day simple moving average is $11.28.

ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.05. The firm had revenue of $116.66 million during the quarter, compared to analyst estimates of $112.60 million. ZimVie had a positive return on equity of 6.37% and a negative net margin of 4.39%. Analysts predict that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

ZimVie Profile

(Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Featured Articles

Institutional Ownership by Quarter for ZimVie (NASDAQ:ZIMV)

Should You Invest $1,000 in ZimVie Right Now?

Before you consider ZimVie, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.

While ZimVie currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines